Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Warts × Tuberculin × Clear all

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cryotherapy 7 resiquimod 5 Cantharidin 4 Cholecalciferol 3 PRA1 protein, Candida albicans 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Measles-Mumps-Rubella Vaccine 2 2-Propanol 2 plerixafor 1 methyl 5-aminolevulinate 1 green tea extract polyphenone E 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 VP-102 1 Tuberculin 1 Trichloroacetic Acid 1 Sugars 1 Photochemotherapy 1 Nitric Oxide 1 Mass Screening 1 Maltose 1 Lasers 1 Interferon-alpha 1 Imiquimod 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Granulocyte Colony-Stimulating Factor 1 Gels 1 Filgrastim 1 Exercise 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05254561 2022-02-24

Triple Antigen vs Monoantigen Immunotherapy for Warts

Zagazig University

Phase 2/3 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡